论文部分内容阅读
目的:探讨中西医结合治疗老年糖尿病性骨质疏松的临床效果。方法:选取糖尿病性骨质疏松患者65例,随机分为对照组32例和观察组33例。对照组患者给予美康达单纯西药治疗,观察组患者给予美康达联合中药治疗,比较两组患者治疗总有效率、骨痛程度改善情况和骨痛缓解时间。结果:经过治疗,观察组患者治疗总有效率为90.9%,显著高于对照组的68.8%,差异有统计学意义(P<0.05);治疗后,观察组患者VAS评分为(1.1±0.2)分,显著低于对照组的(3.2±0.3)分,差异有统计学意义(P<0.01);观察组患者骨痛缓解时间为(4.7±0.5)周,显著低于对照组的(9.1±1.2)周,差异有统计学意义(P<0.01)。结论:中西医联合疗法治疗老年糖尿病性骨质疏松,可提高临床治疗效果,有效缓解患者骨痛,值得临床推广应用。
Objective: To explore the clinical effect of integrated traditional Chinese and western medicine on senile diabetic osteoporosis. Methods: Sixty-five diabetic patients with osteoporosis were randomly divided into control group (n = 32) and observation group (n = 33). Patients in the control group were treated with metronidazole only western medicine. Patients in the observation group were treated with metronidazole combined with traditional Chinese medicine. The total effective rate, the degree of bone pain and the pain relief time were compared between the two groups. Results: After treatment, the total effective rate of observation group was 90.9%, which was significantly higher than that of control group (68.8%), the difference was statistically significant (P <0.05); After treatment, the VAS score of observation group was (1.1 ± 0.2) (P <0.01). The relief time of pain in the observation group was (4.7 ± 0.5) weeks, which was significantly lower than that in the control group (9.1 ± 1.2) weeks, the difference was statistically significant (P <0.01). Conclusion: The combination therapy of traditional Chinese and western medicine for the treatment of senile diabetic osteoporosis can improve the clinical curative effect and effectively relieve the bone pain in patients, which is worthy of clinical application.